In our prior work in MESA and three additional cohorts, we found that apoA1 in HDL that contained apoC3 was directly associated with CHD risk, whereas apoA1 in HDL that lacked apoC3 was inversely associated with CHD risk [10]. This evidence concerns the gene APOC3 and coronary artery disorder.